Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Inflammation ; 32(4): 247-51, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19543820

ABSTRACT

Alveolar macrophages (AM) are the primary target cell of the lung for inhaled mycobacterial pathogens. We investigated the effect of the synthetic lipopeptide MALP-2 on the interaction between AM from rats and Mycobacterium bovis BCG. AM were infected with M. bovis BCG at a multiplicity of infection (MOI) of 10 and then cultured in medium alone or medium supplemented with either synthetic macrophage activating lipopeptide-2 (MALP-2), or IFN-gamma, or both. Mycobacterial CFU were counted on days 3 and 7 and cell-free supernatants were collected for cytokine measurements. Treatment of macrophages with MALP-2 led to reduced bacterial loads by day 3 and 7 post-infection and at the same time enhanced the release of TNF-alpha, IL-6 und IL-10 compared to non-stimulated, M. bovis BCG-infected AM. Macrophages co-treated with MALP-2 and IFN-gamma or IFN-gamma in the absence of MALP-2 limited the growth of M. bovis BCG only by day 3, but not day 7 post-stimulation. Our data show that MALP-2 is effective in decreasing bacterial loads in lung sentinel cells.


Subject(s)
Lipopeptides/pharmacology , Macrophages, Alveolar/microbiology , Mycobacterium bovis/drug effects , Animals , Colony Count, Microbial , Cytokines/analysis , Interferon-gamma/pharmacology , Lipopeptides/chemical synthesis , Lung/microbiology , Lung/pathology , Mycobacterium bovis/growth & development , Rats , Tuberculosis/microbiology , Tuberculosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL